Better healthspan with
Naturally occurring molecules have demonstrated their potential in many clinical and preclinical trials as treatments for optimizing human health and aging.
The volume of positive clinical and preclinical results around two molecules in particular – NMN and NAD+ – made these a logical choice as our leadoff research and development focus.
What is NAD+?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in all living cells. It is a mediator of key cellular and metabolic functions and is central to energy production and system repair in the body.
As we age, NAD+ levels dramatic decline. Countering this decline by modulating NAD+ usage or synthesis has been shown to prolong both healthspan and lifespan.
What is NMN?
NMN (nicotinamide mononucleotide) is the direct precursor of NAD+ and is an essential component to increase NAD+ levels in the body.
Boosting NAD+ levels via dietary NMN supplementation has been shown to support biochemical pathways that can lower the risk of having or developing many aging-associated conditions or diseases.
The hallmarks of aging
NMN, NAD+ and other molecules we harness have been shown preclinically and clinically to mitigate, delay, or even reverse cellular damage that leads to expression of age-related health decline.
Is it via this targeted treatment of the cellular causes of aging that NMN-C® can help to slow the appearance– and reduce the burden of – the hallmarks of aging.
Altered intercellular communication
The future: synergetic solutions
Given the connected biology of human health, it is no surprise that some of the most powerful molecules for optimizing healthspan do not operate in isolation.
Certain molecules can be co-opted to work with others in complimentary ways.
Our extensive scientific experience enables us to explore synergetic combinations of molecules that deliver benefits beyond those offered by even the most bioactive single-molecule solutions.
It’s a new age for healthspan.